DVA: DaVita Inc. Stock

SIC 809 – Miscellaneous Health And Allied Services, Not

Valuation
Market Cap ($M) 11,135.27
Enterprise Value ($M) 20,834.09
Book Value ($M) 2,743.35
Book Value / Share 31.28
Price / Book 4.06
NCAV ($M) -11,012.32
NCAV / Share -125.57
Price / NCAV -1.01

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.31

Liquidity (mrq)
Quick Ratio 1.13
Current Ratio 1.19

Balance Sheet (mrq) ($M)
Current Assets 3,137.91
Assets 16,893.58
Liabilities 14,150.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 12,140.15
Operating Income 1,701.00
Net Income 691.53
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,059.03
Cash from Investing -771.80
Cash from Financing -1,170.49

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-16 13D/A Berkshire Hathaway Inc 41.20 0.00
02-13 13G/A Vanguard Group Inc 6.92 2.51
01-31 13G/A BlackRock Inc. 5.20 -0.66

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-01 215,685 744,429 28.97
2024-02-29 169,159 1,041,200 16.25
2024-02-28 155,756 706,665 22.04
2024-02-27 174,199 854,369 20.39

(click for more detail)

Similar Companies
AGL – agilon health, inc.


Financial data and stock pages provided by
Fintel.io